1,096
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

GMFG (glia maturation factor gamma) inhibits lung cancer growth by activating p53 signaling pathway

, &
Pages 9284-9293 | Received 18 Dec 2021, Accepted 01 Mar 2022, Published online: 06 Apr 2022

References

  • Houston T. Screening for Lung Cancer. Med Clin North Am. 2020;104(6):1037–1050.
  • Suster DI, Mino-Kenudson M. Molecular Pathology of Primary Non-small Cell Lung Cancer. Arch Med Res. 2020;51(8):784–798.
  • Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer. Lancet. 2021;398(10299):535–554.
  • Boczkowska M, Rebowski G, Dominguez R. Glia maturation factor (GMF) interacts with Arp2/3 complex in a nucleotide state-dependent manner. J Biol Chem. 2013;288(36):25683–25688.
  • Lippert DN, Wilkins JA. Glia maturation factor gamma regulates the migration and adherence of human T lymphocytes. BMC Immunol. 2012;13(1):21.
  • Zuo P, Fu Z, Tao T, et al. The expression of glia maturation factors and the effect of glia maturation factor-gamma on angiogenic sprouting in zebrafish. Exp Cell Res. 2013;319(5):707–717.
  • Ikeda K, Kundu RK, Ikeda S, et al. Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ Res. 2006;99(4):424–433.
  • Aerbajinai W, Ghosh MC, Liu J, et al. Glia maturation factor-gamma regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS. Blood Adv. 2019;3(8):1211–1225.
  • Zuo P, Ma Y, Huang Y, et al. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer. Gynecol Oncol. 2014;132(3):745–751.
  • Wang H, Chen Z, Chang H, et al. Expression of glia maturation factor gamma is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro. Oncol Rep. 2017;37(2):929–936.
  • Yang Y, He X, Tang QQ, et al. GMFG has potential to be a novel prognostic marker and related to immune infiltrates in breast cancer. Front Oncol. 2021;11:629633.
  • Lan A, Ren C, Wang X, et al. Bioinformatics and survival analysis of glia maturation factor-gamma in pan-cancers. BMC Cancer. 2021;21(1):423.
  • Tomczak K, Czerwinska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol. 2015;19(1A):A68–77.
  • Wu M, Shang X, Sun Y, et al. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets. PeerJ. 2020;8:e8961.
  • Doench JG, Fusi N, Sullender M, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184–191.
  • Shahid S, Shahid W, Shaheen J, et al. Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia. Sci Rep. 2021;11(1):22783.
  • Zhang L, Cheng H, Yue Y, et al. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/beta-catenin in ox-LDL -stimulated vascular smooth muscle cells. J Biomed Sci. 2018;25(1):11.
  • Garcia-Maquilon I, Rodriguez PL, Vaidya AS, et al. A Luciferase Reporter Assay to Identify Chemical Activators of ABA Signaling. Methods Mol Biol. 2021;2213:113–121.
  • Liu J, Zhang C, Wang J, et al. The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway. Int J Mol Sci. 2020;21.
  • Yang FY, Zhang L, Zheng Y, et al. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling. Bioengineered. 2022;13(1):1377–1387.
  • Duffy MJ, Synnott NC, Crown J. Mutant p53 as a target for cancer treatment. Eur J Cancer. 2017;83:258–265.
  • Hong B, van den Heuvel AP, Prabhu VV, et al. Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities. Curr Drug Targets. 2014;15(1):80–89.
  • Zhang T, Li Y, Zhu R, et al. Transcription Factor p53 Suppresses Tumor Growth by Prompting Pyroptosis in Non-Small-Cell Lung Cancer. Oxid Med Cell Longev. 2019;2019:8746895.
  • Fan Y, Wang Y, Fu S, et al. Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax. Exp Ther Med. 2019;18(3):1563–1570.
  • Kim EM, Jung CH, Kim J, et al. The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins. Cancer Res. 2017;77(11):3092–3100.
  • Molinie N, Gautreau A. The Arp2/3 Regulatory System and Its Deregulation in Cancer. Physiol Rev. 2018;98(1):215–238.
  • Rotty JD, Wu C, Bear JE. New insights into the regulation and cellular functions of the ARP2/3 complex. Nature reviews. Mol Cell Biol. 2013;14(1):7–12.
  • Zuchero JB, Coutts AS, Quinlan ME, et al. p53-cofactor JMY is a multifunctional actin nucleation factor. Nat Cell Biol. 2009;11(4):451–459.